Large-scale testing (Phase 3)Study completedNCT01358864
What this trial is testing
Efficacy and Safety of BI 201335 (Faldaprevir) in Combination With Pegylated Interferon-alpha and Ribavirin in Treatment-Experienced Genotype 1 Hepatitis C Infected Patients (STARTverso 3)
Who this might be right for
Hepatitis C, Chronic
Boehringer Ingelheim 678